[Long-term follow up of central nervous system leukemia in children (author's transl)]. 1979

T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
November 1975, Klinische Padiatrie,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
August 1981, Zhonghua fang she xue za zhi Chinese journal of radiology,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
February 1982, Anales espanoles de pediatria,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
January 1978, Sangre,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
February 2011, Pediatric blood & cancer,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
July 1993, Cancer,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
January 1981, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
November 1978, Monatsschrift fur Kinderheilkunde,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
January 1976, Padiatrie und Padologie,
T Yokoyama, and T Fujimoto, and M Ito, and K Furusho, and H Kin, and A Hasegawa
February 1980, Ryumachi. [Rheumatism],
Copied contents to your clipboard!